Chevron Corporation
CVX
$224.99
+2.59%
Chevron Corporation is a fully integrated energy major engaged in worldwide exploration and production of crude oil and natural gas, LNG, refining, and chemicals, with 2025 net oil-equivalent production of roughly 3.7 million barrels per day and 1.8 million barrels per day of refining capacity across the U.S. and Asia. As the second-largest U.S. oil company by production and a dividend aristocrat with a roughly 4.5% yield, Chevron occupies a defensive, cash-return-oriented position in the energy sector rather than a high-growth one, distinguished by a low-beta profile and a conservative balance sheet relative to integrated peers. The current investor narrative centers on the Hess integration and the strategic simplification of the portfolio — notably the divestiture of Hess Midstream at a $3-4 billion accounting hit that management frames as cutting Bakken midstream costs by roughly half — alongside a $7 billion commitment to Venezuela and potential entry into Iraq as long-cycle growth options. Sentiment has been further supported by elevated crude prices tied to Strait of Hormuz tensions and a U.S.-Venezuela oil agreement, while debate persists over whether the stock's sharp re-rating already discounts peak-cycle cash flows and whether the elevated payout ratio is sustainable.…
CVX
Chevron Corporation
$224.99
Related headlines
Investment Opinion: Should I buy CVX Today?
Rating: Hold. Chevron is a high-quality integrated energy major with a strong balance sheet and robust cash flow, but after a 48% one-year rally, the stock appears fairly valued with limited near-term upside. The analyst consensus is 'buy' with a mean rating of 1.72 and an average target price of $227.92, implying just 1.3% upside from the current $224.99, suggesting the market has already priced in much of the good news.
The supporting evidence includes a forward PE of 14.77x, which is attractive relative to the trailing PE of 22.92x and implies expected EPS growth of ~55% to $13.85. Revenue growth is strong at 51.43% YoY in Q2 2026, and profitability has expanded with a net margin of 17.96% and gross margin of 45.52%. Free cash flow is robust at $27.01 billion TTM, comfortably covering dividends and buybacks, and the debt-to-equity ratio of 0.219 is conservative. The EV/EBITDA of 7.70x is within the typical range for integrated majors, suggesting the stock is not expensive on a cash flow basis.
However, risks include the sustainability of peak-cycle refining margins, a dividend payout ratio above 100% on trailing earnings, and execution risks in Venezuela and Iraq. The stock is also technically overextended near its 52-week high. The rating would upgrade to Buy if the stock pulls back to the $200-207 support zone or if forward EPS estimates rise, and it would downgrade to Sell if refining margins collapse or if the dividend is cut. Relative to its own history, the P/B of 1.51x is near the low end of its range, but the PE is in the upper-middle, suggesting the stock is fairly valued to slightly overvalued on earnings but cheap on book value.
Sign up to view all
CVX 12-Month Price Forecast
Chevron is a high-quality energy major that has delivered exceptional returns over the past year, but the stock now appears fairly valued with limited near-term upside. The forward valuation is reasonable, and the balance sheet is strong, but peak-cycle earnings and a stretched dividend payout ratio pose risks. Analyst sentiment is positive but the average target implies minimal upside, and the wide target range reflects disagreement about earnings durability. I would upgrade to bullish if the stock pulls back to the $200-207 support zone or if crude prices sustainably rise above $90, and downgrade to bearish if refining margins contract sharply or if the dividend is cut.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Chevron Corporation's 12-month outlook, with a consensus price target around $227.92 and implied upside of +1.3% versus the current price.
Average Target
$227.92
0 analysts
Implied Upside
+1.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$175 - $253
Analyst target range
Coverage is deep and institutional, with 24 analysts and a consensus recommendation of "buy" (mean rating 1.72 on a 1-5 scale where 1 is Strong Buy), and an average target price of $227.92 — implying just +1.3% upside from the current $224.99, a notably thin margin that signals the stock has essentially caught up to consensus fair value. The consensus leans bullish in rating but neutral in implied return, a classic late-stage setup where analysts like the business but see limited near-term price appreciation after a 48% run; the estimated average EPS of $13.85 and revenue of $236.08 billion underpin the forward PE of 14.77x and suggest the Street expects earnings normalization rather than further multiple expansion. The target range is wide, from a low of $175.00 (-22.2% downside) to a high of $253.00 (+12.5% upside), a spread of roughly 45% of the current price that signals meaningful disagreement about the durability of current cash flows. The high target of $253 likely assumes sustained elevated crude prices from Hormuz tensions, successful Hess integration with midstream cost savings, and progress on Venezuela's $7 billion expansion doubling low-cost production — essentially a scenario of multiple expansion on peak-cycle earnings. The low target of $175 prices in mean reversion in refining margins, a normalization of crude prices, and the $3-4 billion Hess Midstream divestiture hit flowing through earnings, plus execution risk in Venezuela and Iraq. Recent institutional actions show stability rather than momentum: TD Cowen reiterated Hold (September 28), HSBC reiterated Buy (September 25), while BMO, Wells Fargo, and Piper Sandler all reiterated Outperform/Overweight in early September, and Barclays and Bernstein stayed at Equal Weight/Market Perform — a pattern of conviction-holding rather than fresh upgrades, consistent with a stock that has already delivered its re-rating and now needs fundamental delivery to justify further gains.
Drowning in data?
Find the real signal!
Bulls vs Bears: CVX Investment Factors
The bull case for Chevron rests on its strong Q2 2026 earnings surge, robust free cash flow, conservative balance sheet, and attractive forward valuation, supported by strategic portfolio moves. However, the bear case highlights the stock's thin analyst upside, peak-cycle earnings risk, a dividend payout ratio above 100%, technical overextension, and execution/geopolitical risks. Currently, the bear evidence appears slightly stronger due to the stock's proximity to its 52-week high and limited analyst target upside, suggesting the easy money has been made. The single most important tension is whether the elevated refining margins and crude prices—driven by geopolitical tensions—are sustainable; if they normalize, earnings and the dividend coverage could come under pressure, potentially leading to a significant de-rating. Conversely, if these conditions persist and growth projects deliver, the stock could break out to new highs.
Bullish
- Q2 2026 earnings surge: Q2 2026 net income reached $12.07 billion with EPS of $6.13, a massive jump from $2.21 billion (EPS $1.12) in Q1 2026. This demonstrates the company's earnings leverage to refining margins and crude prices, with net margin expanding to 17.96% from 4.65% sequentially.
- Strong free cash flow generation: Q2 2026 operating cash flow was $22.63 billion and free cash flow $18.10 billion, with TTM FCF of $27.01 billion. This comfortably funds $3.50 billion in dividends and $3.00 billion in buybacks, highlighting the sustainability of shareholder returns despite a 103.7% payout ratio on trailing GAAP earnings.
- Conservative balance sheet: Debt-to-equity is only 0.219 and the current ratio is 1.155, with interest coverage exceeding 60x in Q2 2026 (interest expense of $352 million vs. operating income of $21.48 billion). This provides resilience through commodity cycles and supports the dividend aristocrat status.
- Attractive forward valuation: Forward PE of 14.77x is well below the trailing PE of 22.92x, implying the market expects EPS to grow ~55% to $13.85. EV/EBITDA of 7.70x is within the typical 6-9x range for integrated majors, suggesting the stock is not expensive on a cash flow basis despite the 48% one-year rally.
Bearish
- Thin analyst upside: The average analyst target price of $227.92 implies only 1.3% upside from the current $224.99, indicating the stock has caught up to consensus fair value. The consensus rating is 'buy' (1.72 mean), but the lack of price upside suggests limited near-term appreciation.
- Peak-cycle earnings risk: Q2 2026 gross margin of 45.52% is far above the 29.7-31.8% range of the prior eight quarters, driven by elevated refining crack spreads amid Hormuz tensions. Revenue growth of 51.43% YoY is largely price-driven, and any normalization in crude prices or refining margins could sharply reduce earnings.
- Dividend payout ratio above 100%: The payout ratio of 103.7% on trailing earnings means the dividend is not covered by GAAP net income, relying on cash flow that can be volatile. Q1 2026 free cash flow was negative $1.55 billion, showing how quickly the model can swing with working capital and prices.
- Technical overextension: The stock is trading at $224.99, just $0.32 below its 52-week high of $225.31, after a 48.30% one-year gain and 44.32% YTD. With a beta of only 0.523, such a sharp move is statistically notable and raises the risk of mean reversion, especially with no bearish divergence yet but little margin of safety.
CVX Technical Analysis
Chevron is in a powerful, sustained uptrend: the stock is up 48.30% over the past year and 44.32% year-to-date, closing at $224.99 against a 52-week range of $146.49 to $225.31 — trading at approximately 99.8% of its 52-week range and effectively pressing against all-time-high territory. That positioning signals strong momentum and trend confirmation, but also leaves little margin of safety and raises the risk of overextension, particularly with the price sitting just $0.32 below the 52-week high. The stock's relative strength versus the S&P 500 is emphatic, with 32.77 percentage points of 1-year outperformance (SPY +15.53% vs. CVX +48.30%), underscoring that this is a leadership name rather than a laggard catching up. Short-term momentum is accelerating rather than fading: the stock gained 6.36% in the past month and 20.07% over three months, both far ahead of SPY's 1.22% and 2.69%, producing relative strength readings of +5.14 and +17.38 points respectively. The most recent session added 2.59% on a close of $224.99 versus a previous close of $219.32, and the 6-month gain of 22.28% versus SPY's 7.48% confirms a persistent, multi-horizon divergence in Chevron's favor rather than a one-off spike. Because the 1-month, 3-month, and 1-year trends are all aligned upward, there is no bearish divergence to flag; the main risk is mean reversion after a parabolic run into the highs. Key technical levels are well defined: support sits at the 52-week low of $146.49, with intermediate support likely in the $200-207 zone where the stock consolidated through September, while resistance is the 52-week high of $225.31 — a clean breakout above which would confirm a new leg higher, whereas a rejection could trigger a pullback toward the $200 area. Volatility is unusually low for an energy major, with a beta of just 0.523, meaning the stock has historically moved roughly half as much as the market; combined with a maximum drawdown of -21.53% over the period, this supports larger position sizing on a risk-adjusted basis but also means the current 48% run is statistically notable for such a low-beta name. The short ratio of 2.38 indicates minimal short-seller pressure, removing a potential squeeze catalyst but also confirming the move is fundamentally rather than positioning-driven.
Beta
0.52
0.52x market volatility
Max Drawdown
-21.5%
Largest decline past year
52-Week Range
$146-$225
Price range past year
Annual Return
+48.3%
Cumulative gain past year
| Period | CVX Return | S&P 500 |
|---|---|---|
| 1m | +6.4% | +0.2% |
| 3m | +20.1% | +2.9% |
| 6m | +22.3% | +8.4% |
| 1y | +48.3% | +14.9% |
| ytd | +44.3% | +11.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CVX Fundamental Analysis
Revenue has inflected sharply upward: Q2 2026 revenue reached $67.20 billion, up 51.43% year-over-year from $44.38 billion in Q2 2025, a dramatic acceleration from the roughly $45.8-48.2 billion quarterly run-rate seen through 2025. The segment mix shows Downstream at $49.65 billion and Upstream at $17.53 billion, with All Other negligible at $25 million — meaning the downstream/refining complex, likely benefiting from elevated crack spreads amid Hormuz-related crude tightness, is the dominant revenue driver, while upstream provides the margin-rich backbone. Sequentially, revenue rose from $47.56 billion in Q1 2026 to $67.20 billion in Q2, a 41% jump in a single quarter, which implies the growth is cyclical and price-driven rather than structural volume expansion — a critical distinction for durability of the investment case. Profitability has expanded materially: Q2 2026 net income was $12.07 billion with a net margin of 17.96%, gross margin of 45.52%, and operating margin of 31.96%, versus Q1 2026's much weaker $2.21 billion net income, 4.65% net margin, and 9.58% gross margin. The Q1-to-Q2 swing reflects both higher realizations and the absence of the large other-expense drag ($4.79 billion in Q2 versus a $706 million gain in Q1), and the Q2 gross margin of 45.52% is well above the 29.7-31.8% range typical of the prior eight quarters, suggesting peak-cycle refining economics. Trailing metrics are far more modest — net margin of 6.67%, operating margin of 9.04%, and gross margin of 30.41% — confirming that the trailing twelve months still carry the weight of weaker 2025 quarters, and ROE of 6.60% and ROA of 5.86% remain below what a mid-cycle integrated major typically earns. The balance sheet is a clear strength: debt-to-equity of just 0.219, a current ratio of 1.155, and interest coverage that has ranged from 9.4x to 61x across recent quarters, with Q2 2026 interest expense of only $352 million against $21.48 billion of operating income. Cash generation is robust — Q2 2026 operating cash flow of $22.63 billion and free cash flow of $18.10 billion against capital expenditure of $4.54 billion, with TTM free cash flow of $27.01 billion — comfortably funding $3.50 billion of dividends and $3.00 billion of buybacks in the quarter. The caveat is the payout ratio of 103.7% on trailing earnings and a dividend yield of 4.52%, which means the dividend is currently covered by cash flow but not by trailing GAAP net income; the Q1 2026 free cash flow deficit of -$1.55 billion also shows how quickly the model can swing with working capital and prices.
Quarterly Revenue
$67.2B
2026-06
Revenue YoY Growth
+51.4%
YoY Comparison
Gross Margin
45.5%
Latest Quarter
Free Cash Flow
$27.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CVX Overvalued?
Because Chevron is solidly profitable (Q2 2026 net income of $12.07 billion; trailing EPS positive), the PE ratio is the appropriate primary metric, and the trailing PE of 22.92x against a forward PE of 14.77x implies the market expects earnings to grow roughly 55% — consistent with consensus EPS of $13.85 versus the depressed trailing figure. That wide trailing-to-forward gap is the single most important valuation signal here: the market is not paying 23x for today's earnings but roughly 15x for normalized, recovery-level earnings, which is a far more reasonable proposition for an integrated major. On the secondary metrics, the stock trades at 1.51x book, 1.53x sales, 2.22x EV/sales, and 7.70x EV/EBITDA — the EV/EBITDA multiple is the most telling, sitting comfortably inside the 6-9x band typical for integrated oil majors and suggesting the enterprise is not richly valued on a cash-flow basis despite the 48% price run. Peer comparison is constrained by the absence of a formal industry-average dataset, but the observed multiples can be benchmarked against typical integrated-major norms: a 1.51x P/B and 7.70x EV/EBITDA are broadly in line with, or modestly below, the 1.5-2.0x book and 6-8x EBITDA ranges historically commanded by Exxon and Shell, implying Chevron trades at a slight discount to its quality tier rather than a premium. The 1.53x P/S looks low in absolute terms but is distorted by the downstream-heavy revenue base, which carries structurally thin margins; the 4.52% dividend yield versus a sector-typical 3.5-4.5% is at the high end, offering income support. Historically, Chevron's own PE has ranged from roughly 6.0x in mid-2022 (peak earnings) to 46.2x in Q1 2026 (trough earnings), with the current 22.92x sitting in the upper-middle of that band — but this is an artifact of the earnings cycle rather than multiple expansion, since the price-to-book of 1.51x is near the low end of its 1.43-2.23x historical range. The PEG ratio of -0.72 is not meaningful given the negative growth denominator and should be disregarded; the more relevant read is that P/B near multi-year lows alongside a forward PE of 14.77x suggests the market is pricing in solid but not euphoric expectations, leaving room for re-rating if the Hess integration and Venezuela/Iraq growth deliver.
PE
22.9x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 6x~30x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
7.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are moderate but notable. The dividend payout ratio of 103.7% on trailing earnings means the dividend is not covered by GAAP net income, relying on cash flow that can be volatile; Q1 2026 free cash flow was negative $1.55 billion, showing how quickly the model can swing with working capital and prices. Additionally, the company's earnings are highly sensitive to refining margins and crude prices, with Q2 2026 gross margin of 45.52% well above the historical range of 29.7-31.8%, indicating peak-cycle conditions. The $3-4 billion hit from the Hess Midstream divestiture and the $7 billion Venezuela commitment add execution and political risks, while the low beta of 0.523 does not protect against commodity-specific downturns.
Market and competitive risks include valuation compression if earnings normalize. The stock trades at a forward PE of 14.77x, which is reasonable but assumes EPS growth of ~55% to $13.85; if crude prices fall or refining margins contract, earnings could disappoint, leading to multiple compression. The stock's 48.30% one-year gain has pushed it to near its 52-week high, and the average analyst target of $227.92 offers only 1.3% upside, suggesting limited margin of safety. Competitive pressures from other integrated majors and the risk of regulatory changes, especially in Venezuela and Iraq, could also impact performance. The low short ratio of 2.38 indicates minimal short-seller pressure, but that also means no squeeze catalyst.
Worst-case scenario: A sharp decline in crude prices and refining margins, coupled with execution issues in Venezuela and a failure to realize Hess synergies, could trigger a re-rating. The stock could fall to its 52-week low of $146.49, representing a 34.9% decline from the current $224.99. The analyst low target of $175 implies a 22.2% downside, but the 52-week low is a more extreme scenario. Given the max drawdown of -21.53% over the period, a 35% drop is plausible in a severe downturn, especially if the dividend is cut or growth projects are delayed.
FAQ
The most severe risk is a sharp decline in crude oil prices and refining margins, which could significantly reduce earnings and cash flow; Q2 2026 gross margin of 45.52% is well above the historical range, indicating peak-cycle conditions. Second, the dividend payout ratio of 103.7% on trailing earnings means the dividend is not covered by GAAP net income, and a prolonged downturn could force a cut. Third, execution and geopolitical risks are elevated with the $7 billion Venezuela commitment and potential Iraq entry, where political instability could disrupt operations. Fourth, the stock is technically overextended near its 52-week high after a 48% run, and with a beta of 0.523, a mean reversion could be sharp. These risks are ranked from most to least severe, with commodity price risk being the primary driver.
Our 12-month forecast for CVX includes a bull case (25% probability) with a target range of $240-253, a base case (55% probability) of $210-235, and a bear case (20% probability) of $146-175. The base case is most likely, assuming crude prices moderate to $80-85 and refining margins normalize, leading the stock to trade around the analyst average target of $227.92. The bull case requires sustained high crude prices and successful execution of growth projects, while the bear case envisions a sharp drop in oil prices and margin compression. The key assumption behind the base case is that earnings settle at mid-cycle levels and the dividend remains covered by free cash flow.
CVX appears fairly valued to slightly overvalued on earnings but cheap on book value. The trailing PE of 22.92x is above the historical mid-cycle range, but the forward PE of 14.77x suggests the market expects earnings to grow 55% to $13.85 per share. The EV/EBITDA of 7.70x is within the typical 6-9x range for integrated majors, and the P/B of 1.51x is near the low end of its historical range of 1.43-2.23x. The dividend yield of 4.52% is at the high end of the sector, providing income support. Overall, the market is pricing in solid but not euphoric expectations, with limited margin of safety given the stock's proximity to its 52-week high and the average analyst target offering only 1.3% upside.
CVX is a high-quality energy major with strong fundamentals, but the risk/reward is balanced after a 48% one-year rally. The stock trades at $224.99, just below its 52-week high of $225.31, and the average analyst target of $227.92 implies only 1.3% upside. The forward PE of 14.77x is attractive, and the 4.5% dividend yield is well-supported by $27 billion in TTM free cash flow, but the payout ratio of 103.7% on trailing earnings raises questions about dividend sustainability. The biggest downside risk is a normalization in refining margins, which could compress earnings and lead to a 22-35% decline toward the analyst low target of $175 or the 52-week low of $146.49. For long-term income investors, CVX is a solid holding, but new buyers may want to wait for a pullback to the $200-207 support zone for a better margin of safety.
CVX is best suited for long-term investment, particularly for income-focused investors seeking a reliable dividend and lower volatility. The stock's beta of 0.523 indicates it moves roughly half as much as the market, making it a defensive holding. The 4.52% dividend yield and strong free cash flow generation support a buy-and-hold strategy, and the company's long-cycle growth projects in Venezuela and Iraq offer potential upside over several years. However, short-term trading is less attractive given the stock's proximity to its 52-week high and limited analyst upside; a pullback to the $200-207 support zone could present a better entry point. A suggested minimum holding period is 2-3 years to capture the full benefit of dividend compounding and growth project execution.